These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 19697391

  • 1. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
    Murdande SB, Pikal MJ, Shanker RM, Bogner RH.
    J Pharm Sci; 2010 Mar; 99(3):1254-64. PubMed ID: 19697391
    [Abstract] [Full Text] [Related]

  • 2. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals.
    Murdande SB, Pikal MJ, Shanker RM, Bogner RH.
    Pharm Res; 2010 Dec; 27(12):2704-14. PubMed ID: 20859662
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Practical Estimation of Amorphous Solubility Enhancement Using Thermoanalytical Data: Determination of the Amorphous/Crystalline Solubility Ratio for Pure Indomethacin and Felodipine.
    Skrdla PJ, Floyd PD, Dell'orco PC.
    J Pharm Sci; 2016 Sep; 105(9):2625-2630. PubMed ID: 27372548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.
    Paus R, Ji Y, Vahle L, Sadowski G.
    Mol Pharm; 2015 Aug 03; 12(8):2823-33. PubMed ID: 26107071
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.
    Murdande SB, Pikal MJ, Shanker RM, Bogner RH.
    Pharm Dev Technol; 2011 Jun 03; 16(3):187-200. PubMed ID: 20429826
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD, Lee PI.
    Mol Pharm; 2015 Apr 06; 12(4):1203-15. PubMed ID: 25775257
    [Abstract] [Full Text] [Related]

  • 19. Different amorphous solid-state forms of roxithromycin: A thermodynamic and morphological study.
    Milne M, Liebenberg W, Aucamp ME.
    Int J Pharm; 2016 Feb 10; 498(1-2):304-15. PubMed ID: 26705157
    [Abstract] [Full Text] [Related]

  • 20. A quantitative model to evaluate solubility relationship of polymorphs from their thermal properties.
    Mao C, Pinal R, Morris KR.
    Pharm Res; 2005 Jul 10; 22(7):1149-57. PubMed ID: 16028016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.